InvestSMART

ChemGenex Pharmaceuticals Ltd (ASX: CXS) - Announcements

DELISTED - Current share price for CXS : $0.700

ASX company news and announcements for ChemGenex Pharmaceuticals Ltd (CXS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ChemGenex Pharmaceuticals Ltd (CXS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ChemGenex Pharmaceuticals Ltd (CXS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ChemGenex Pharmaceuticals Ltd (CXS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Suspension at close of trading 21/6/11 21 Jun 2011 10:07AM $0.700 $0.700 fallen by 0%
- Notice of Compulsory Acquisition 14 Jun 2011 3:05PM $0.690 $0.700 risen by 1.45%
- Notice of Variation of Offer: Extension of Offer Period 14 Jun 2011 1:17PM $0.690 $0.700 risen by 1.45%
- Notice Under Sec 630(3) - Status of Defeating Conditions 6 Jun 2011 8:29AM $0.695 $0.700 risen by 0.72%
- Notice under Sec 650F re Cephalon T/O 1 Jun 2011 10:26AM $0.695 $0.700 risen by 0.72%
- Extension of Office Period 27 May 2011 1:36PM $0.695 $0.700 risen by 0.72%
- Notice under Section 650F of Corps Act 27 May 2011 12:34PM $0.695 $0.700 risen by 0.72%
- Cephalon CXS Holdings PL Notice of Acceptances 27 May 2011 9:27AM $0.695 $0.700 risen by 0.72%
- Supplementary Bidder`s Statement 20 May 2011 2:46PM n/a $0.700 n/a
- Variation of Takeover Bid 13 May 2011 12:18PM $0.690 $0.700 risen by 1.45%
- Supplementary Bidder`s Statement 4 May 2011 12:20PM $0.695 $0.700 risen by 0.72%
- First Supplementary Bidder`s Statement 29 Apr 2011 11:20AM $0.665 $0.700 risen by 5.26%
- Off market takeover bid by Cephalon 27 Apr 2011 9:55AM $0.665 $0.700 risen by 5.26%
- Bidder`s Statement and Target`s Statement 13 Apr 2011 4:41PM n/a $0.700 n/a
- Cephalon Update 30 Mar 2011 12:11PM $0.650 $0.700 risen by 7.69%
- Cephalon Launches Takeover Bid 29 Mar 2011 9:55AM $0.675 $0.700 risen by 3.70%
- Trading Halt 25 Mar 2011 10:11AM $0.440 $0.700 risen by 59.09%
- Half Yearly Report and Accounts 18 Feb 2011 12:18PM $0.700 $0.700 fallen by 0%
- ChemGenex to Align European and US Regulatory Strategies 5 Jan 2011 9:25AM $0.460 $0.700 risen by 52.17%
- Awarded U.S. Therapeutic Discovery grant 2 Nov 2010 2:22PM $0.550 $0.700 risen by 27.27%
- Convertible Note Issued to Cephalon, Inc 22 Oct 2010 10:37AM $0.505 $0.700 risen by 38.61%
- Response to an ASX Price Query 5 Oct 2010 9:35AM $0.480 $0.700 risen by 45.83%
- ChemGenex Completes pre-NDA Meeting with U.S. FDA 5 Oct 2010 9:21AM $0.480 $0.700 risen by 45.83%
- Preliminary Final Report 27 Aug 2010 1:32PM $0.345 $0.700 risen by 102.90%
- FDA agrees on potential regulatory pathway for OMAPRO 14 Jul 2010 9:23AM $0.380 $0.700 risen by 84.21%

1 - 25 of 105 results

Page 1 of 5

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.